ALI HEALTH(00241)2023-05-23 14:27Financial Performance - For the fiscal year ending March 31, 2023, Alibaba Health reported total revenue of approximately RMB 26,763.0 million, representing a year-on-year growth of 30.1%[5] - The company achieved a gross profit of RMB 5,701.3 million, which is a 38.8% increase from the previous year[5] - The adjusted net profit for the year was RMB 751.4 million, compared to a loss of RMB 394.3 million in the previous year[5] - The company's revenue for the fiscal year ending March 31, 2023, was RMB 26,763,016,000, an increase of RMB 6,185,400,000 or 30.1% compared to RMB 20,577,616,000 in the previous year[20] - Gross profit reached RMB 5,701,334,000, up RMB 1,593,341,000 or 38.8%, with a gross margin of 21.3%, an increase from 20.0% in the prior year[24] - The company reported a profit before tax of RMB 550,994 thousand, a significant recovery from a loss of RMB 252,514 thousand in the previous year[46] - Net profit attributable to equity holders of the parent company was RMB 533,407 thousand, compared to a loss of RMB 265,555 thousand in 2022, marking a turnaround in profitability[46] - Basic earnings per share for the year was RMB 3.95, compared to a loss per share of RMB 1.97 in the previous year[46] Revenue Breakdown - The revenue from the self-operated pharmaceutical business was approximately RMB 23,591.6 million, reflecting a year-on-year increase of 31.7%[3] - The healthcare and digital services business reported revenue of RMB 933,486,000, a significant increase of 45.7% compared to the previous year[23] - Revenue from the pharmaceutical e-commerce platform business totaled RMB 2,237,953,000, representing a 10.5% increase year-on-year[22] - Revenue from product sales was RMB 22,578,076 thousand, up 32% from RMB 17,128,890 thousand in 2022[58] - Revenue from services provided reached RMB 4,184,940 thousand, an increase of 21.3% from RMB 3,448,726 thousand in the previous year[58] User Engagement and Growth - The active users on the Tmall Health platform reached nearly 300 million, with an average annual spending on health products continuing to rise[3] - The number of active consumers in the online self-operated stores exceeded 130 million, an increase of over 20 million compared to the previous year[3] - The number of chronic disease users served by the company approached 9 million, with a year-on-year growth of 35.2%[4] - The number of pharmaceutical self-operated user members reached 75 million, reflecting a year-on-year growth of 47.4%[9] - The average daily online consultation service volume exceeded 400,000, with nearly 200,000 licensed healthcare professionals providing online health consultation services[7] Operational Efficiency - The company has established a distribution network with 39 warehouses across 22 locations, enhancing operational efficiency through smart supply chain systems[3] - The group has formed strategic partnerships with hundreds of pharmaceutical companies, establishing 19 "Health Care Centers" for comprehensive health management services[9] - The group is focused on leveraging digital technology and operational capabilities to provide accessible and efficient healthcare services to millions of families[7] Cash Flow and Financial Position - Cash and cash equivalents as of March 31, 2023, were RMB 10,917,171,000, up from RMB 10,547,851,000 a year earlier[35] - Net cash flow from operating activities was RMB 255,690,000, a decrease from RMB 424,363,000 in the previous year[36] - The company reported a net cash outflow from investing activities of RMB 532,436,000, primarily due to increases in time deposits and cash used for acquisitions[38] - The company had no outstanding borrowings as of March 31, 2023, indicating a capital debt ratio of zero[40] Corporate Governance - The company has maintained compliance with corporate governance codes, ensuring shareholder and stakeholder interests are protected[74] - The audit committee reviewed the annual performance, confirming alignment with the consolidated financial statements for the reporting period[77] - The board of directors includes executive and independent members, ensuring a balanced governance structure[79]